Wearable Device Intervention to Improve Sun Behaviors in Melanoma Survivors
2 other identifiers
interventional
368
1 country
1
Brief Summary
Over 5 million new cases of skin cancer are diagnosed in the United States each year, more than all other cancers combined. Most of these cases are caused by excess exposure to ultraviolet radiation from the sun and artificial sources such as indoor tanning. Melanoma, approximately 87,000 of the annual skin cancer cases and one of the more deadly skin cancers, is on the rise. Previous research on these individuals suggests that while some change how much time they spend in the sun and adopt ways to protect themselves when in the sun, many do not. In our previous study, we found that 20% of melanoma survivors reported a sunburn in the past year and 10% intentionally went outside for a tan, both strong indicators of inappropriate sun exposure. Melanoma survivors are at high risk of second melanomas, making it critical that they spend less time in the sun or take actions to protect themselves when they are in the sun. No studies to date have investigated technology-based strategies in melanoma survivors to improve sun exposure and protection behaviors. This project will test whether a wearable device that tracks sun exposure and provides alerts regarding sun exposure and protection behaviors will increase sun protection behaviors in melanoma survivors. The use of wearable technology devices (e.g., Fitbit) has grown quickly over the last decade and studies using these devices to promote physical activity and weight loss have been promising. We will test the technology device versus a similar control device in 368 melanoma survivors and compare sun protection behaviors between the two groups. This project has the potential to identify a strategy that could significantly lower the number of melanoma survivors who go on to have a second melanoma diagnosis. Importantly, this easy to use technology could also be utilized by survivors' family members, who are also at higher risk for melanoma, and the general population as a means to reduce risk of all forms of skin cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2019
CompletedFirst Posted
Study publicly available on registry
April 25, 2019
CompletedStudy Start
First participant enrolled
June 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2022
CompletedResults Posted
Study results publicly available
May 13, 2024
CompletedMay 13, 2024
December 1, 2023
1.4 years
April 15, 2019
February 24, 2023
December 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sun Protection Habits Index
Sun protection habits measured using Glanz et al., 2008 questionnaire and scored by taking the averaging of 6 protective behaviors (wearing a shirt with sleeves, wearing sunglasses, staying in the shade, using sunscreen, limiting time in the sun, and wearing a hat) on a 4-point ordinal scale ranging from 1 = rarely or never to 4 = always. (Glanz et al. 2010). Higher score indicates better sun protection behaviors
12 weeks (post intervention)
Secondary Outcomes (1)
Number of Participants With Sunburn in the Past 12 Weeks
12 weeks (post intervention)
Study Arms (2)
Shade and application with UV message activated
EXPERIMENTALwearable device (wrist) and associated mobile application; UV sensor exposure display and messaging activated
Shade and application without UV messaging
ACTIVE COMPARATORwearable device (wrist) and associated mobile application; UV sensor exposure display and messaging not activated
Interventions
Shade wearable device and application with UV messaging activated
Shade wearable device and application without UV messaging activated
Eligibility Criteria
You may qualify if:
- years old
- Diagnosed with cutaneous invasive melanoma within HealthPartners system
- Able to read/write in English
- Own a smartphone
- Able to provide voluntary informed consent
You may not qualify if:
- Patients who have opted out of their records being used for research purposes
- Inability to provide informed written consent
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Minnesotalead
- American Cancer Society, Inc.collaborator
- Melanoma Research Alliancecollaborator
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Related Publications (2)
Vogel RI, Luo X, Brown K, Jewett P, Dona AC, Nagler RH, Ahmed RL, Martinson BC, Lazovich D. A UVR-sensor wearable device intervention to reduce sun exposure in melanoma survivors: Results from a randomized controlled trial. PLoS One. 2023 Feb 10;18(2):e0281480. doi: 10.1371/journal.pone.0281480. eCollection 2023.
PMID: 36763627DERIVEDVogel RI, Nagler RH, Ahmed RL, Brown K, Luo X, Martinson BC, Lazovich D. UVR-sensor wearable device intervention to improve sun behaviors and reduce sunburns in melanoma survivors: study protocol of a parallel-group randomized controlled trial. Trials. 2020 Nov 23;21(1):959. doi: 10.1186/s13063-020-04881-3.
PMID: 33228807DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Rachel Vogel
- Organization
- University of Minnesota
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 15, 2019
First Posted
April 25, 2019
Study Start
June 9, 2020
Primary Completion
November 1, 2021
Study Completion
October 31, 2022
Last Updated
May 13, 2024
Results First Posted
May 13, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share